Breaking News Instant updates and real-time market news.

KMI

Kinder Morgan

$20.14 /

-0.045 (-0.22%)

15:19
10/16/19
10/16
15:19
10/16/19
15:19

Kinder Morgan options imply 3.4% move in share price post-earnings

Pre-earnings options volume in Kinder Morgan is normal with calls leading puts 2:1. Implied volatility suggests the market is anticipating a move near 3.4%, or 69c, after results are released. Median move over the past eight quarters is 1.3%.

  • 16

    Oct

KMI Kinder Morgan
$20.14 /

-0.045 (-0.22%)

10/02/19 TD Securities
TD Securities starts Kinder Morgan at Buy with $25 price target
10/02/19 TD Securities
Kinder Morgan initiated with a Buy at TD Securities
09/10/19
Kinder Morgan downgraded to Hold from Buy at Argus
09/10/19 Argus
Kinder Morgan downgraded to Hold from Buy at Argus

TODAY'S FREE FLY STORIES

Recommendations
Blueprint Medicines price target raised to $95 from $85 at Deutsche Bank » 07:39
07/15/20
07/15
07:39
07/15/20
07:39
BPMC

Blueprint Medicines

$79.68 /

+2.86 (+3.72%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

06:30 Today H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Piper Sandler
Blueprint Medicines' deal with Roche neutral on model, says Piper Sandler
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
RHHBY Roche
$0.00 /

+ (+0.00%)

06:30 Today H.C. Wainwright
Blueprint Medicines price target raised to $110 from $66 at H.C. Wainwright
07/14/20 Baird
Blueprint Medicines price target raised to $100 from $90 at Baird
07/14/20 Piper Sandler
Blueprint Medicines' deal with Roche neutral on model, says Piper Sandler
07/14/20 Raymond James
Blueprint Medicines price target raised to $106 from $95 at Raymond James
BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

RHHBY Roche
$0.00 /

+ (+0.00%)

  • 23
    Jan
RHHBY Roche
$0.00 /

+ (+0.00%)

BPMC Blueprint Medicines
$79.68 /

+2.86 (+3.72%)

RHHBY Roche
$0.00 /

+ (+0.00%)

Hot Stocks
Cytokinetics provides update on cardiovascular pipeline, commercial strategies » 07:38
07/15/20
07/15
07:38
07/15/20
07:38
CYTK

Cytokinetics

$27.88 /

+3.73 (+15.45%)

Cytokinetics management…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

07:17 Today Cantor Fitzgerald
Cytokinetics price target raised to $41 from $29 at Cantor Fitzgerald
06:38 Today JMP Securities
Cytokinetics price target raised to $29 from $23 at JMP Securities
07/14/20 H.C. Wainwright
Cytokinetics price target raised to $38 from $35 at H.C. Wainwright
07/14/20 Piper Sandler
Cytokinetics price target raised to $33 from $28 at Piper Sandler
CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

CYTK Cytokinetics
$27.88 /

+3.73 (+15.45%)

Recommendations
Boston Beer price target raised to $540 from $481 at Deutsche Bank » 07:38
07/15/20
07/15
07:38
07/15/20
07:38
SAM

Boston Beer

$622.27 /

+32.44 (+5.50%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

07/14/20 Evercore ISI
Boston Beer initiated with an Outperform at Evercore ISI
06/10/20 Guggenheim
Boston Beer price target raised to $609 from $549 at Guggenheim
06/08/20 RBC Capital
Boston Beer price target raised to $575 from $427 at RBC Capital
06/01/20 Cowen
Boston Beer price target raised to $650 from $570 at Cowen
SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

SAM Boston Beer
$622.27 /

+32.44 (+5.50%)

Hot Stocks
Goldman Sachs sees 2020 global GDP down 3.4%, 2021 GDP up 6.2% » 07:37
07/15/20
07/15
07:37
07/15/20
07:37
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

Goldman previously…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Initiation
Church & Dwight initiated with a Buy at Argus » 07:36
07/15/20
07/15
07:36
07/15/20
07:36
CHD

Church & Dwight

$84.46 /

+2.33 (+2.84%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

07:25 Today Argus
Church & Dwight initiated with a Buy at Argus
06/24/20 Oppenheimer
Church & Dwight price target raised to $88 from $83 at Oppenheimer
06/18/20
Fly Intel: Top five analyst upgrades
06/18/20 Credit Suisse
Credit Suisse upgrades Church & Dwight, says 'built to withstand' recession
CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

Earnings
OpGen reports Q2 preliminary revenue $1.2M, one est. $1.2M » 07:36
07/15/20
07/15
07:36
07/15/20
07:36
OPGN

OpGen

$1.98 /

-0.085 (-4.12%)

OpGen announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
OPGN OpGen
$1.98 /

-0.085 (-4.12%)

OPGN OpGen
$1.98 /

-0.085 (-4.12%)

06/09/20 Alliance Global Partners
Alliance Global Partners sees OpGen preliminary data as positive
06/03/20 Alliance Global Partners
OpGen, NYS DOH collaboration extension 'highly positive,' says Alliance Global
OPGN OpGen
$1.98 /

-0.085 (-4.12%)

Hot Stocks
Novocure, Merck enter clinical trial collaboration to develop NSCLC treatment » 07:35
07/15/20
07/15
07:35
07/15/20
07:35
NVCR

Novocure

$58.12 /

+0.04 (+0.07%)

, MRK

Merck

$78.26 /

+0.88 (+1.14%)

Novocure (NVCR) announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVCR Novocure
$58.12 /

+0.04 (+0.07%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

NVCR Novocure
$58.12 /

+0.04 (+0.07%)

07/10/20 Piper Sandler
Novocure glioblastoma opportunity in China underappreciated, says Piper Sandler
07/06/20 Mizuho
Novocure has large growth opportunity in China, says Mizuho
05/20/20 Piper Sandler
Novocure remains top idea in oncology equipment at Piper Sandler
05/13/20 Piper Sandler
Piper says Novocure opens up largest GBM market with China approval
MRK Merck
$78.26 /

+0.88 (+1.14%)

06/30/20 SVB Leerink
Seattle Genetics price target raised to $167 from $155 at SVB Leerink
06/30/20 Oppenheimer
Seattle Genetics price target raised to $210 from $200 at Oppenheimer
06/25/20 Lake Street
Lake Street says Keytruda approval improves outlook for Checkpoint's cosibelimab
06/23/20 Maxim
Inovio price target raised to $24 from $18 at Maxim
NVCR Novocure
$58.12 /

+0.04 (+0.07%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

NVCR Novocure
$58.12 /

+0.04 (+0.07%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

MRK Merck
$78.26 /

+0.88 (+1.14%)

Hot Stocks
Moleculin Biotech partners with Sterling Pharma to produce COVID-19 candidate » 07:34
07/15/20
07/15
07:34
07/15/20
07:34
MBRX

Moleculin Biotech

$0.79 /

-0.0168 (-2.10%)

Moleculin Biotech has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MBRX Moleculin Biotech
$0.79 /

-0.0168 (-2.10%)

MBRX Moleculin Biotech
$0.79 /

-0.0168 (-2.10%)

04/08/20 Roth Capital
Moleculin can expedite COVID candidate amid less restrictions, says Roth Capital
10/17/19 Oppenheimer
Moleculin Biotech initiated with an Outperform at Oppenheimer
Earnings
Organogenesis sees Q2 revenue $68M-$68.6M, consensus $48.25M » 07:32
07/15/20
07/15
07:32
07/15/20
07:32
ORGO

Organogenesis

$3.25 /

-0.09 (-2.69%)

Net revenue is based…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ORGO Organogenesis
$3.25 /

-0.09 (-2.69%)

ORGO Organogenesis
$3.25 /

-0.09 (-2.69%)

03/06/20 Credit Suisse
Organogenesis price target lowered to $8 from $10 at Credit Suisse
01/10/20 SVB Leerink
Organogenesis initiated with an Outperform at SVB Leerink
08/26/19 Credit Suisse
Organogenesis reinstated with an Outperform at Credit Suisse
ORGO Organogenesis
$3.25 /

-0.09 (-2.69%)

  • 22
    Nov
Downgrade
Marvell downgraded to Equal Weight after recent rally at Wells Fargo » 07:32
07/15/20
07/15
07:32
07/15/20
07:32
MRVL

Marvell

$37.21 /

+0.53 (+1.44%)

Wells Fargo analyst Gary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

06:01 Today Wells Fargo
Marvell downgraded to Equal Weight from Overweight at Wells Fargo
07/07/20 Needham
Marvell price target raised to $39 from $34 at Needham
07/06/20 Rosenblatt
Samsung on track to replace Nokia as 5G RAN supplier at Verizon, says Rosenblatt
05/29/20 Susquehanna
Marvell delivered results beyond expectations, says Susquehanna
MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

MRVL Marvell
$37.21 /

+0.53 (+1.44%)

Downgrade
Verrica Pharmaceuticals downgraded to Neutral from Buy at BofA » 07:30
07/15/20
07/15
07:30
07/15/20
07:30
VRCA

Verrica Pharmaceuticals

/

+

BofA analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
VRCA Verrica Pharmaceuticals
/

+

VRCA Verrica Pharmaceuticals
/

+

06/30/20 H.C. Wainwright
Verrica Pharmaceuticals price target lowered to $18 from $24 at H.C. Wainwright
06/24/20 Northland
Verrica Pharmaceuticals initiated with an Outperform at Northland
03/24/20
Fly Intel: Top five analyst initiations
03/24/20 Needham
Verrica Pharmaceuticals initiated with a Buy at Needham
VRCA Verrica Pharmaceuticals
/

+

VRCA Verrica Pharmaceuticals
/

+

Recommendations
PVH Corp. price target lowered to $52 from $55 at BMO Capital » 07:30
07/15/20
07/15
07:30
07/15/20
07:30
PVH

PVH Corp.

$46.52 /

+1.14 (+2.51%)

BMO Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

06/15/20 DA Davidson
PVH Corp. price target raised to $60 from $41 at DA Davidson
06/15/20 Barclays
PVH Corp. price target lowered to $51 from $67 at Barclays
06/15/20 RBC Capital
PVH Corp. price target raised to $48 from $30 at RBC Capital
06/12/20 Deutsche Bank
PVH Corp. price target lowered to $42 from $44 at Deutsche Bank
PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

PVH PVH Corp.
$46.52 /

+1.14 (+2.51%)

Hot Stocks
Goldman Sachs reports Q2 Investment Banking net revenues $2.66B » 07:29
07/15/20
07/15
07:29
07/15/20
07:29
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

Net revenues in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Hot Stocks
Goldman CEO: Recent turbulence reinforces commitment to strategy » 07:28
07/15/20
07/15
07:28
07/15/20
07:28
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

Chairman and CEO David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Hot Stocks
Goldman Sachs reports Q2 ROE 11.1%, 1H ROE 8.4% » 07:28
07/15/20
07/15
07:28
07/15/20
07:28
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

Annualized return on…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Hot Stocks
Goldman Sachs reports Q2 FICC sales and trading revenue $4.24B  07:27
07/15/20
07/15
07:27
07/15/20
07:27
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

 
ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Earnings
Goldman Sachs reports Q2 EPS $6.26, consensus $3.78 » 07:27
07/15/20
07/15
07:27
07/15/20
07:27
GS

Goldman Sachs

$214.29 /

+5.36 (+2.57%)

Reports Q2 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

07/08/20 Seaport Global
Goldman Sachs initiated with a Buy at Seaport Global
06/26/20 Morgan Stanley
Morgan Stanley sees dividend cuts at Wells Fargo, Capital One after stress tests
06/05/20 Wells Fargo
Goldman Sachs price target raised to $255 from $230 at Wells Fargo
06/04/20
Fly Intel: Top five analyst downgrades
GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

GS Goldman Sachs
$214.29 /

+5.36 (+2.57%)

Recommendations
First Republic price target raised to $85 from $68 at Wells Fargo » 07:26
07/15/20
07/15
07:26
07/15/20
07:26
FRC

First Republic

$108.81 /

+1.99 (+1.86%)

Wells Fargo analyst Jared…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FRC First Republic
$108.81 /

+1.99 (+1.86%)

FRC First Republic
$108.81 /

+1.99 (+1.86%)

06/01/20 JPMorgan
First Republic price target raised to $130 from $120 at JPMorgan
05/05/20 Atlantic Equities
Atlantic Equities upgrades First Republic to Neutral on mortgage refi boost
05/05/20 Atlantic Equities
First Republic upgraded to Neutral from Underweight at Atlantic Equities
04/15/20 BMO Capital
First Republic price target raised to $99 from $90 at BMO Capital
FRC First Republic
$108.81 /

+1.99 (+1.86%)

  • 15
    Jan
Hot Stocks
Taiwan Liposome announces manuscript on strategy to treat COVID-19 » 07:26
07/15/20
07/15
07:26
07/15/20
07:26
TLC

Taiwan Liposome

$6.72 /

+0.22 (+3.38%)

TLC announced that a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TLC Taiwan Liposome
$6.72 /

+0.22 (+3.38%)

TLC Taiwan Liposome
$6.72 /

+0.22 (+3.38%)

12/23/19 Cantor Fitzgerald
Taiwan Liposome assumed with an Overweight at Cantor Fitzgerald
Recommendations
General Mills price target raised to $72 from $66 at Guggenheim » 07:26
07/15/20
07/15
07:26
07/15/20
07:26
GIS

General Mills

$65.15 /

+1.59 (+2.50%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GIS General Mills
$65.15 /

+1.59 (+2.50%)

GIS General Mills
$65.15 /

+1.59 (+2.50%)

07/02/20 BMO Capital
General Mills price target raised to $66 from $63 at BMO Capital
06/29/20 Jefferies
Jefferies staying sidelined on General Mills ahead of earnings
06/11/20 Bernstein
General Mills downgraded to Underperform from Market Perform at Bernstein
05/21/20 Jefferies
General Mills price target raised to $61 from $56 at Jefferies
GIS General Mills
$65.15 /

+1.59 (+2.50%)

GIS General Mills
$65.15 /

+1.59 (+2.50%)

GIS General Mills
$65.15 /

+1.59 (+2.50%)

GIS General Mills
$65.15 /

+1.59 (+2.50%)

Initiation
Church & Dwight initiated with a Buy at Argus » 07:25
07/15/20
07/15
07:25
07/15/20
07:25
CHD

Church & Dwight

$84.46 /

+2.33 (+2.84%)

Argus analyst John…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

06/24/20 Oppenheimer
Church & Dwight price target raised to $88 from $83 at Oppenheimer
06/18/20
Fly Intel: Top five analyst upgrades
06/18/20 Credit Suisse
Credit Suisse upgrades Church & Dwight, says 'built to withstand' recession
06/18/20 Credit Suisse
Church & Dwight upgraded to Outperform from Neutral at Credit Suisse
CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

CHD Church & Dwight
$84.46 /

+2.33 (+2.84%)

Conference/Events
Morgan Stanley analysts hold analyst/industry conference call » 07:25
07/15/20
07/15
07:25
07/15/20
07:25

Global Head of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley IT hardware analysts to hold an analyst/industry conference call » 07:25
07/15/20
07/15
07:25
07/15/20
07:25

Asia EM Equity Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Syndicate
Alector 2.7M share Block Trade priced at $19.55 » 07:23
07/15/20
07/15
07:23
07/15/20
07:23
ALEC

Alector

$22.49 /

-0.03 (-0.13%)

Morgan Stanley acted as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALEC Alector
$22.49 /

-0.03 (-0.13%)

ALEC Alector
$22.49 /

-0.03 (-0.13%)

06/24/20 H.C. Wainwright
Alector initiated with a Buy at H.C. Wainwright
04/28/20 Goldman Sachs
Alector initiated with a Buy at Goldman Sachs
03/06/20 Citi
Citi starts Alector at Buy, recommends for dementia space exposure
03/05/20 Citi
Alector initiated with a Buy at Citi
ALEC Alector
$22.49 /

-0.03 (-0.13%)

  • 30
    Jan
Recommendations
Fox Corp. price target lowered to $29 from $32 at Guggenheim » 07:23
07/15/20
07/15
07:23
07/15/20
07:23
FOXA

Fox Corp.

$25.02 /

+0.08 (+0.32%)

, FOX

Fox Corp.

$25.14 /

+0.08 (+0.32%)

Guggenheim analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FOXA Fox Corp.
$25.02 /

+0.08 (+0.32%)

FOX Fox Corp.
$25.14 /

+0.08 (+0.32%)

FOXA Fox Corp.
$25.02 /

+0.08 (+0.32%)

07/13/20
Fly Intel: Top five analyst initiations
07/13/20 Goldman Sachs
Fox Corp. initiated with a Sell at Goldman Sachs
06/19/20 Macquarie
Macquarie upgrades Fox to Neutral on better ad market
06/19/20 Macquarie
Fox Corp. upgraded to Neutral from Underperform at Macquarie
FOX Fox Corp.
$25.14 /

+0.08 (+0.32%)

05/28/20 Jefferies
Flutter Entertainment share sale a 'confident, proactive step,' says Jefferies
04/13/20 Citi
Fox Corp. resumed with a Neutral at Citi
04/06/20 Wells Fargo
Fox Corp. price target lowered to $20 from $33 at Wells Fargo
04/02/20 Guggenheim
Guggenheim upgrades Fox to Buy on live news, late-season sports exposure
FOXA Fox Corp.
$25.02 /

+0.08 (+0.32%)

FOX Fox Corp.
$25.14 /

+0.08 (+0.32%)

FOXA Fox Corp.
$25.02 /

+0.08 (+0.32%)

FOX Fox Corp.
$25.14 /

+0.08 (+0.32%)

FOXA Fox Corp.
$25.02 /

+0.08 (+0.32%)

FOX Fox Corp.
$25.14 /

+0.08 (+0.32%)

FOXA Fox Corp.
$25.02 /

+0.08 (+0.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.